comparemela.com

Rebecca Weil News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph D as Chief Commercial Officer as it Enters Pre-Commercial Phase

Following the achievement of two positive key late-stage clinical milestones on its lead product candidate OCS-01 and recent listing on NASDAQ, Oculis is strengthening its executive leadership team with the appointment of Rebecca Weil, Ph.D., seasoned global ophthalmology commercial executive, as Chief Commercial OfficerOCS-01’s recent positive topline results in Phase 3 DIAMOND Stage 1 trial for diabetic macular edema (DME) and in Phase 3 OPTIMIZE trial for inflammation and pain following catar

Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph D as Chief Commercial Officer as it Enters Pre-Commercial Phase - Oculis Holding (NASDAQ:OCS)

Following the achievement of two positive key late-stage clinical milestones on its lead product candidate OCS-01 and recent listing on NASDAQ, Oculis is strengthening its executive leadership team with the appointment

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.